NCT00980187View on ClinicalTrials.gov

A Comparison of Indapamide SR 1.5 mg With HCTZ 25 mg, in Combination With an ACE-inhibitor, in Patients With Mild to Moderate AHT and Type 2 DM

PHASE4CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 31, 2008

Primary Completion Date

August 31, 2010

Study Completion Date

August 31, 2010

Conditions
HypertensionType 2 Diabetes Mellitus
Interventions
DRUG

Hydrochlorothiazide

orally, 25 mg, once a day, with Quinapril 10-40 mg, 6 months

DRUG

Indapamide

1.5 mg SR, orally, once a day,with Quinapril 10-40 mg, 6 months

Trial Locations (1)

050098

Cardiology, University and Emergency Hospital, Bucharest

Sponsors
All Listed Sponsors
lead

LaborMed Pharma S.A.

INDUSTRY